blue cross blue shield glp 1 coverage 2026 Weight Loss Drug from FEHB Plans and Medicare GLP-1 | Blue Cross and

78 Recent rigorous scientific studies, specifically randomized controlled trials, have proven that GLP-1RAs consistently offer substantial weight loss advantages beyond the early stages of treatment

Consider complementary treatments Many patients combine Semaglutide with IV hydration therapy for energy, hormone optimization to address metabolic factors, or peptide therapy for additional support

Treatment duration varies by individual goals and response

drinking a lot of alcohol

Cardiovascu- lar safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes

Talk to your doctor